ANG Lifesciences India Ltd - 540694 - Closure of Trading Window
Intimation of Closure of Trading window from 1st October, 2023 till the disclosure of Unaudited Standalone & Consolidated Financial results for the half year and quarter ended 30th September, 2023. ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisment for Notice of AGM ANG Lifesciences India Ltd - 540694 - Reg. 34 (1) Annual Report.
Previously in cause of bulk file, there has been some typographical error in the report therefore we enclosed the revised Annual Report for your reference. ANG Lifesciences India Ltd - 540694 - Reg. 34 (1) Annual Report.
Please find enlosed herewith Annual Report 2022-23 ANG Lifesciences India Ltd - 540694 - Notice Of 17Th Annual General Meeting Of The Shareholders Of The Company
In pursuant to Reg 30 of SEBI LODR 2015, please find enclosed the notice of AGM for FY 2022-23 ANG Lifesciences India Ltd - 540694 - Intimation Of Book Closure
In pursunat to Reg 42 of SEBI LODR, 2015 and section 91 of Companies act 2013, the Registerof members an Share Transfer book of the company shall remian closed from 24.09.2023 to 30.09.2023 and cut-off date is 23.09.2023 for evoting ANG Lifesciences India Ltd - 540694 - Board Meeting Outcome for Outcome Of Board Meeting
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, We hereby inform you that the Board of Directors of the Company in its meeting held on today, 05" September, 2023 at its registered office at SCO 113, Darbara Complex, First Floor, District Shopping Centre B Block, Ranjit Avenue, Amritsar, Punjab, 143001, have inter-alia discussed, considered and approved the agendas as mentioned herewith outcome ANG Lifesciences India Ltd - 540694 - Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015
ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 ('LODR'), we hereby inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, September 5th, 2023 at 4:30 PM at the Registered Office of the Company to transact the agendas as mentioned in the enclosed Notice of Board Meeting. ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisment of the Consolidated and Standalone Financial Result for the quarter ended as at 30.06.2023 ANG Lifesciences India Ltd - 540694 - Financial Result For Quarter Ended As At 30.06.2023
Financial Result with limited review report for quarter ended as at 30.06.2023